UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM N-Q

 

QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED

MANAGEMENT INVESTMENT COMPANY

 

Investment Company Act file number: 811-21712

 

CLOUGH GLOBAL EQUITY FUND

(Exact name of registrant as specified in charter)

 

1290 Broadway, Suite 1100, Denver, Colorado 80203

(Address of principal executive offices) (Zip code)

 

Karen S. Gilomen, Secretary

Clough Global Equity Fund

1290 Broadway, Suite 1100

Denver, Colorado 80203

(Name and address of agent for service)

 

Registrant’s telephone number, including area code: (303) 623-2577

 

Date of fiscal year end: October 31

 

Date of reporting period: January 31, 2019

 

 

Item 1 – Schedule of Investments.

 

The Schedule of Investments is included herewith.

 

Clough Global Dividend and Income Fund
STATEMENT OF INVESTMENTS
January 31, 2019 (Unaudited)

 

   Shares   Value 
COMMON STOCKS 78.22%
Communication Services 4.66%
China Mobile, Ltd.   258,500   $2,711,118 
Nintendo Co., Ltd.   1,706    529,851 
T-Mobile US, Inc.(a)(b)   10,900    758,858 
         3,999,827 
           
Consumer Discretionary 3.83%
DR Horton, Inc.(b)(c)   37,226    1,431,340 
Lennar Corp. - Class A(b)(c)   39,200    1,858,864 
         3,290,204 
           
Energy 0.10%
Fairway Energy LP(a)(d)(e)(f)(g)(h)   130,700    81,296 
           
Financials 32.38%
Ares Capital Corp.(b)   164,300    2,678,090 
Bank of America Corp.(b)(c)   102,791    2,926,460 
Barings BDC, Inc.(b)(c)   115,900    1,147,410 
Blackstone Mortgage Trust, Inc. - Class A(b)   89,700    3,093,753 
China Life Insurance Co., Ltd. - Class H   722,000    1,779,433 
Citigroup, Inc.(b)(c)   62,130    4,004,900 
Golub Capital BDC, Inc.(b)   89,700    1,639,716 
Granite Point Mortgage Trust, Inc.(b)   52,100    1,016,992 
JPMorgan Chase & Co.(b)(c)   16,500    1,707,750 
Ladder Capital Corp.(b)   49,652    859,476 
Morgan Stanley   8,200    346,860 
Ping An Insurance Group Co. of China, Ltd. - Class H   94,000    909,196 
Solar Capital, Ltd.(b)   75,100    1,540,301 
Starwood Property Trust, Inc.(b)   138,800    3,064,704 
TPG Specialty Lending, Inc.(b)   54,600    1,082,718 
         27,797,759 
           
Health Care 11.88%
Amgen, Inc.(b)   7,590    1,420,165 
Anthem, Inc.(b)(c)   4,720    1,430,160 
Eli Lilly & Co.(b)(c)   10,200    1,222,572 
Humana, Inc.(b)(c)   2,855    882,166 
Johnson & Johnson(b)(c)   5,150    685,362 
Pfizer, Inc.(b)   61,900    2,627,655 
UnitedHealth Group, Inc.(b)(c)   4,300    1,161,860 
Zoetis, Inc.(b)(c)   8,900    766,824 
         10,196,764 
           
Information Technology 18.92%
Broadcom, Ltd.(b)(c)   5,820    1,561,215 
Cisco Systems, Inc.(b)(c)   26,200    1,238,998 
Cypress Semiconductor Corp.   51,600    715,692 
KLA-Tencor Corp.   6,800    724,676 
Lam Research Corp.   4,280    725,802 
Marvell Technology Group, Ltd.   39,100    724,523 
    Shares    Value 
Information Technology (continued)
Micron Technology, Inc.(a)(b)(c)   48,000   $1,834,560 
Microsoft Corp.   18,000    1,879,740 
NXP Semiconductors NV   8,400    731,052 
Samsung Electronics Co., Ltd.   86,821    3,601,123 
Visa, Inc. - Class A(b)   13,300    1,795,633 
Xilinx, Inc.(b)(c)   6,300    705,222 
         16,238,236 
           
Real Estate 6.45%
China Resources Land, Ltd.   198,000    769,579 
Community Healthcare Trust, Inc.(b)   94,900    3,133,598 
SBA Communications Corp.(a)(b)(c)   8,950    1,633,643 
         5,536,820 
           
TOTAL COMMON STOCKS
(Cost $64,251,401)        67,140,906 
           
CLOSED-END FUNDS 3.69%
Aberdeen Income Credit Strategies Fund(b)   25,800    300,570 
Aberdeen Total Dynamic Dividend Fund(b)(c)   38,900    318,202 
Advent Claymore Convertible Securities and Income Fund(b)   9,000    127,260 
Apollo Senior Floating Rate Fund, Inc.(b)(c)   24,500    358,435 
Blackstone / GSO Strategic Credit Fund(b)   15,833    227,362 
Brookfield Real Assets Income Fund, Inc.(b)   18,200    383,110 
Cornerstone Strategic Value Fund, Inc.(b)(c)   24,800    301,320 
Cornerstone Total Return Fund, Inc.   25,500    301,410 
Gabelli Convertible and Income Securities Fund, Inc.(b)   32,300    161,823 
KKR Income Opportunities Fund(b)   10,200    153,000 
Royce Value Trust, Inc.(b)   23,700    322,794 
Wells Fargo Multi-Sector Income Fund(b)   17,807    213,862 
           
TOTAL CLOSED-END FUNDS
(Cost $3,044,506)        3,169,148 
           
PREFERRED STOCKS 9.32%
Annaly Capital Management, Inc.
Series H, 8.125%(b)   10,640    272,384 
Series G, 6.500%(b)   37,476    893,053 
Ares Management Corp.
Series A, 7.000%(b)   35,000    938,350 
First Republic Bank
Series D, 5.500%(b)(c)   35,000    818,300 
Global Medical REIT, Inc.
Series A, 7.500%(b)   10,900    270,320 


 

 

           
    Shares    Value 
PREFERRED STOCKS (continued)
M&T Bank Corp.
Series C, 6.375%(b)(c)   962   $962,000 
New Mountain Finance Corp., 5.750%(b)(c)   40,000    996,800 
PennyMac Mortgage Investment Trust
Series A, 3M US L + 5.831%(b)(i)   22,000    555,280 
Series B, 3M US L + 5.99%(b)(i)   10,000    249,400 
Summit Hotel Properties, Inc.
Series E, 6.250%(b)   40,000    810,400 
Two Harbors Investment Corp.
Series A, 3M US L + 5.66%(b)(i)   28,500    750,405 
Series C, 3M US L + 5.011%(b)(c)(i)   20,000    481,000 
           
TOTAL PREFERRED STOCKS
(Cost $8,192,753)        7,997,692 

 

Description and Maturity Date   Principal Amount    Value 
CORPORATE BONDS 19.13%
Bank of America Corp.          
Series FF, Perpetual Maturity, 3M US L + 2.931%(b)(c)(i)(j)   1,000,000    978,525 
Series V, Perpetual Maturity, 3M US L + 3.387%(b)(c)(i)(j)   1,000,000    996,475 
Bayer US Finance II LLC          
07/15/2022, 2.200%(b)(c)(e)  $1,000,000    945,431 
Citizens Financial Group, Inc.          
09/28/2022, 4.150%(b)(c)(e)   1,325,000    1,336,921 
Comcast Corp.          
07/15/2046, 3.400%(b)   750,000    643,431 
Fifth Third Bancorp          
Perpetual Maturity, 3M US L + 3.0333%(b)(i)   750,000    705,169 
Series J, Perpetual Maturity, 3M US L + 3.129%(b)(c)(i)(j)   1,000,000    985,000 
Hercules Capital, Inc.          
10/23/2022, 4.625%(b)(c)   1,000,000    962,592 
Huntington Ingalls Industries, Inc.          
11/15/2025, 5.000%(b)(e)   300,000    306,000 
JPMorgan Chase & Co.          
Series Z, Perpetual Maturity, 3M US L + 3.80%(b)(c)(i)(j)   1,250,000    1,269,181 
Main Street Capital Corp.          
12/01/2019, 4.500%(b)(c)   1,000,000    1,001,859 
12/01/2022, 4.500%(b)(c)   500,000    504,071 
Metropolitan Life Global Funding I          
01/11/2024, 3.600%(b)(e)   700,000    709,409 
NextEra Energy Capital Holdings, Inc.          
10/01/2066, 3M US L + 2.0675%(i)   500,000    437,592 
Penske Truck Leasing Co. LP / PTL Finance Corp.          
03/14/2023, 2.700%(b)(c)(e)   1,000,000    956,566 
Description and Maturity Date   Principal Amount    Value 
CORPORATE BONDS (continued)
People's United Bank National Association          
07/15/2024, 4.000%(b)  $800,000   $798,954 
Solar Capital, Ltd.          
01/20/2023, 4.500%(b)(c)   500,000    472,833 
SVB Financial Group          
01/29/2025, 3.500%   590,000    571,980 
Towne Bank/Portsmouth VA          
07/30/2027, 3M US L + 2.55%(b)(c)(i)   600,000    597,714 
TPG Specialty Lending, Inc.          
01/22/2023, 4.500%(b)(c)   750,000    742,104 
Welltower, Inc.          
04/01/2026, 4.250%   500,000    504,595 
           
TOTAL CORPORATE BONDS          
(Cost $16,654,489)        16,426,402 
           
ASSET/MORTGAGE BACKED SECURITIES 0.11%
United States Small Business Administration          
Series 2008-20L, Class 1, 12/01/2028, 6.220%   86,735    94,585 
           
TOTAL ASSET/MORTGAGE BACKED SECURITIES          
(Cost $86,735)        94,585 
           
GOVERNMENT & AGENCY OBLIGATIONS 23.92%
U.S. Treasury Bonds
08/15/2019, 3.625%   1,000,000    1,005,957 
02/15/2020, 3.625%(b)   4,000,000    4,042,891 
11/15/2026, 6.500%(b)   1,000,000    1,277,187 
08/15/2029, 6.125%(b)   1,000,000    1,317,656 
05/15/2030, 6.250%(b)   1,000,000    1,346,934 
05/15/2037, 5.000%(b)   775,000    1,022,970 
02/15/2041, 4.750%(b)   1,000,000    1,297,930 
05/15/2041, 4.375%(b)   1,000,000    1,236,445 
08/15/2043, 3.625%(b)   1,000,000    1,111,855 
11/15/2043, 3.750%   2,000,000    2,268,476 
05/15/2048, 3.125%(b)   4,500,000    4,603,096 
           
TOTAL GOVERNMENT & AGENCY OBLIGATIONS
(Cost $20,524,209)        20,531,397 

 

    Shares/Principal Amount    Value 
SHORT-TERM INVESTMENTS 3.12%
Money Market Funds  3.12%
BlackRock Liquidity Funds, T-Fund Portfolio - Institutional Class (2.243% 7-day yield)   2,678,126    2,678,126 
         2,678,126 
TOTAL SHORT-TERM INVESTMENTS          
(Cost $2,678,126)        2,678,126 


 

 

         Value 
Total Investments - 137.51%          
(Cost $115,432,219)       $118,038,256 
           
Liabilities in Excess of Other Assets - (37.51%)(k)        (32,197,094)
           
NET ASSETS - 100.00%       $85,841,162 

 

SCHEDULE OF SECURITIES SOLD SHORT (a)   Shares    Value 
COMMON STOCKS (8.40%)
Consumer Staples (0.81%)
Walgreens Boots Alliance, Inc.   (9,600)   (693,696)
           
Financials (3.75%)
American Express Co.   (7,300)   (749,710)
Deutsche Bank AG   (84,400)   (749,472)
Mediobanca Banca di Credito Finanziario SpA   (98,800)   (859,005)
UniCredit SpA   (74,853)   (864,308)
         (3,222,495)
           
Health Care (3.46%)
Alexion Pharmaceuticals, Inc.   (14,300)   (1,758,328)
Cardinal Health, Inc.   (15,400)   (769,538)
McKesson Corp.   (3,480)   (446,310)
         (2,974,176)
           
Industrials (0.38%)
Stericycle, Inc.   (7,300)   (321,784)
           
TOTAL COMMON STOCKS
(Proceeds $7,441,871)        (7,212,151)
           
EXCHANGE TRADED FUNDS (1.05%)
iShares® Nasdaq Biotechnology ETF   (8,200)   (899,458)
 
TOTAL EXCHANGE TRADED FUNDS
(Proceeds $745,478)        (899,458)
           
TOTAL SECURITIES SOLD SHORT          
(Proceeds $8,187,349)       $(8,111,609)

 

Investment Abbreviations:
1D FEDEF - Federal Funds Effective Rate (Daily)
LIBOR - London Interbank Offered Rate
 
Libor Rates:
3M US L - 3 Month LIBOR as of January 31, 2019 was 2.74%

 

(a) Non-income producing security.
(b) Pledged security; a portion or all of the security is pledged as collateral for securities sold short or borrowings. As of January 31, 2019, the aggregate value of those securities was $90,138,164, representing 105.01% of net assets. (See Note 1 and Note 2).
(c) Loaned security; a portion or all of the security is on loan as of January 31, 2019.
(d) Security filed for bankruptcy on November 26, 2018.
(e) Security exempt from registration of the Securities Act of 1933.  These securities may be resold in transactions exempt from registration under Rule 144A, normally to qualified institutional buyers. As of January 31, 2019, these securities had an aggregate value of $4,335,623 or 5.05% of net assets.  These securities have been deemed liquid by the Advisor based on procedures approved by the Board.  (See Note 1)
(f) Private Placement; these securities may only be resold in transactions exempt from registration under the Securities Act of 1933. As of January 31, 2019, these securities had an aggregate value of $81,296 or 0.10% of net assets and have been deemed illiquid by the Adviser based on procedures approved by the Board. (See Note 1).
(g) Fair valued security; valued by management in accordance with procedures approved by the Board. As of January 31, 2019, these securities had an aggregate value of $81,296 or 0.10% of total net assets.
(h) As a result of the use of significant unobservable inputs to determine fair value, these investments have been classified as Level 3 assets. (See Note 1).
(i) Variable rate investment. Interest rates reset periodically. Interest rate shown reflects the rate in effect at January 31, 2019. For securities based on a published reference rate and spread, the reference rate and spread are indicated in the description above.
(j) This security has no contractual maturity date, is not redeemable and contractually pays an indefinite stream of interest.
(k) Includes cash which is being held as collateral for total return swap contracts and securities sold short.


 

 

TOTAL RETURN SWAP CONTRACTS        
         
Counter Party 

Reference

Entity/Obligation

 

Notional

 Amount

 

Floating Rate

Paid by the Fund

 

Floating

Rate Index

 

 Termination

Date

  Value  

Net Unrealized

Appreciation

 
Morgan Stanley  Banco Santander SA  $(826,703)  1D FEDEF - 50 bps  1 D FEDEF  05/20/2020  $(824,726)  $1,977 
Morgan Stanley  Kweichow Moutai Co., Ltd.   3,252,561   1D FEDEF + 250 BPS  1 D FEDEF  05/29/2020   3,473,865    221,304 
      $2,425,858            $2,649,139   $223,281 

 

Counter Party 

Reference

Entity/Obligation

 

Notional

 Amount

 

Floating Rate

Paid by the Fund

 

Floating

Rate Index

 

 Termination

Date

  Value  

Net Unrealized

Depreciation

 
Morgan Stanley  Jiangsu Yanghe Brewery Joint  $1,816,461   1D FEDEF + 255 bps  1 D FEDEF  10/01/2020  $1,527,671   $(288,790)
Morgan Stanley  Jiangsu Yanghe Brewery Joint   112,599   1D FEDEF + 250 bps  1 D FEDEF  5/29/2020   104,288    (8,311)
      $1,929,060            $1,631,959   $(297,101)
      $4,354,918            $4,281,098   $(73,820)

 

 

 

Clough Global Equity Fund
STATEMENT OF INVESTMENTS
January 31, 2019 (Unaudited)

 

   Shares   Value 
COMMON STOCKS 113.32%          
Communication Services 12.80%          
China Mobile, Ltd.   286,500   $3,004,779 
China Tower Corp., Ltd. - Class H(a)   3,062,000    655,545 
GCI Liberty, Inc. - Class A(a)(b)(c)   86,921    4,424,279 
Netflix, Inc.(a)(b)(c)   5,081    1,724,999 
Nintendo Co., Ltd.   3,819    1,186,108 
T-Mobile US, Inc.(a)(b)(c)   92,900    6,467,698 
Zayo Group Holdings, Inc.(a)(b)   44,300    1,216,035 
         18,679,443 
           
Consumer Discretionary 13.09%          
Alibaba Group Holding, Ltd. - Sponsored ADR(a)(b)(c)   39,060    6,581,219 
Amazon.com, Inc.(a)(b)(c)   2,242    3,853,393 
Carvana Co.(a)(b)   44,200    1,642,030 
DR Horton, Inc.(b)(c)   64,621    2,484,678 
Lennar Corp. - Class A(b)(c)   66,700    3,162,914 
Pinduoduo, Inc. - ADR(a)(b)   47,300    1,381,633 
         19,105,867 
           
Energy 0.09%          
Fairway Energy LP(a)(d)(e)(f)(g)(h)   217,600    135,347 
           
Financials 32.15%          
Ares Capital Corp.(b)   324,600    5,290,980 
Bank of America Corp.(b)(c)   168,905    4,808,725 
Blackstone Mortgage Trust, Inc. - Class A(b)   183,900    6,342,711 
China Life Insurance Co., Ltd. - Class H   474,000    1,168,215 
Citigroup, Inc.(b)(c)   90,519    5,834,855 
Golub Capital BDC, Inc.(b)   193,109    3,530,033 
Granite Point Mortgage Trust, Inc.(b)   156,800    3,060,736 
JPMorgan Chase & Co.(b)(c)   27,500    2,846,250 
Ladder Capital Corp.(b)   118,817    2,056,722 
Morgan Stanley   13,900    587,970 
Ping An Insurance Group Co. of China, Ltd. - Class H   92,700    896,622 
Solar Capital, Ltd.(b)   116,000    2,379,160 
Starwood Property Trust, Inc.(b)   301,000    6,646,080 
TPG Specialty Lending, Inc.(b)   74,000    1,467,420 
         46,916,479 
           
Health Care 22.43%          
Align Technology, Inc.(a)(b)(c)   5,310    1,321,925 
Amgen, Inc.(b)   9,300    1,740,123 
Anthem, Inc.(b)(c)   5,890    1,784,670 
Apellis Pharmaceuticals, Inc.(a)(b)(c)   87,697    1,227,758 
BeiGene, Ltd. - ADR(a)(b)(c)   7,000    906,360 
BioMarin Pharmaceutical, Inc.(a)(b)(c)   12,500    1,227,125 

 

   Shares   Value 
Health Care (continued)          
Boston Scientific Corp.(a)(b)(c)   54,000   $2,060,100 
Centrexion Therapeutics(a)(e)(f)(g)(h)   416,666    749,999 
Cigna Corp.(b)   5,815    1,161,895 
Correvio Pharma Corp.(a)(b)(c)   319,900    1,180,431 
CRISPR Therapeutics AG(a)(b)(c)   87,567    2,839,798 
Elanco Animal Health, Inc.(a)(b)   30,800    898,744 
Equillium, Inc.(a)(b)(c)   38,600    339,294 
Galapagos NV - Sponsored ADR(a)(b)(c)   5,900    605,576 
Gossamer Biosciences(a)(e)(f)(g)(h)   264,246    850,000 
GW Pharmaceuticals PLC - ADR(a)(b)   4,690    669,498 
Humana, Inc.(b)(c)   4,765    1,472,337 
IDEXX Laboratories, Inc.(a)   3,000    638,340 
Idorsia, Ltd.(a)(e)   27,100    467,086 
Illumina, Inc.(a)(b)   1,700    475,643 
Intra-Cellular Therapies, Inc.(a)(b)   20,500    246,820 
Johnson & Johnson(b)(c)   7,650    1,018,062 
Pfizer, Inc.(b)(c)   42,200    1,791,390 
Teladoc Health, Inc.(a)(b)(c)   25,000    1,605,000 
UnitedHealth Group, Inc.(b)(c)   5,840    1,577,968 
Veracyte, Inc.(a)(b)(c)   103,000    1,873,570 
Vertex Pharmaceuticals, Inc.(a)(b)(c)   4,020    767,458 
Zoetis, Inc.(b)   14,300    1,232,088 
         32,729,058 
           
Industrials 3.26%          
TransDigm Group, Inc.(a)(b)   12,145    4,748,695 
           
Information Technology 26.65%          
Broadcom, Ltd.(b)(c)   7,020    1,883,115 
Cypress Semiconductor Corp.   87,000    1,206,690 
Guidewire Software, Inc.(a)(b)(c)   13,300    1,152,844 
Inphi Corp(b)(c)   32,200    1,269,968 
KLA-Tencor Corp.   11,400    1,214,898 
Lam Research Corp.   7,200    1,220,976 
Lumentum Holdings, Inc.(a)(b)   37,600    1,839,016 
Marvell Technology Group, Ltd.   66,000    1,222,980 
Micron Technology, Inc.(a)(b)(c)   80,400    3,072,888 
Microsoft Corp.(b)(c)   22,300    2,328,789 
Mimecast, Ltd.(a)   44,500    1,671,865 
NXP Semiconductors NV   14,000    1,218,420 
Pluralsight, Inc. - Class A(a)(b)   34,300    1,028,314 
Proofpoint, Inc.(a)   6,800    692,716 
RingCentral, Inc. - Class A(a)(b)(c)   10,700    989,108 
salesforce.com, Inc.(a)(b)(c)   24,540    3,729,344 
Samsung Electronics Co., Ltd.   145,833    6,048,796 
ServiceNow, Inc.(a)(b)(c)   5,120    1,126,502 
Visa, Inc. - Class A(b)   22,400    3,024,224 
WNS Holdings, Ltd. - ADR(a)(b)(c)   36,000    1,756,440 
Xilinx, Inc.(b)(c)   10,600    1,186,564 
         38,884,457 


 

 

 

   Shares   Value 
Real Estate 2.85%          
Community Healthcare Trust, Inc.(b)   45,800   $1,512,316 
SBA Communications Corp.(a)(b)(c)   14,500    2,646,685 
         4,159,001 
           
TOTAL COMMON STOCKS          
(Cost $157,629,486)        165,358,347 
           
CLOSED-END FUNDS 4.70%          
Aberdeen Income Credit Strategies Fund(b)   17,200    200,380 
Aberdeen Total Dynamic Dividend Fund(b)(c)   88,700    725,566 
Apollo Senior Floating Rate Fund, Inc.(b)   20,000    292,600 
Blackstone / GSO Strategic Credit Fund(b)   12,800    183,808 
Brookfield Real Assets Income Fund, Inc.(b)   14,800    311,540 
Calamos Global Dynamic Income Fund(b)   79,300    611,403 
Cornerstone Strategic Value Fund, Inc.(b)(c)   81,400    989,010 
Cornerstone Total Return Fund, Inc.(b)   84,200    995,244 
Duff & Phelps Global Utility Income Fund, Inc.(b)   29,600    417,656 
First Trust Intermediate Duration Preferred & Income Fund(b)   4,900    105,007 
Gabelli Convertible and Income Securities Fund, Inc.(b)   52,800    264,528 
KKR Income Opportunities Fund(b)   16,504    247,560 
Nuveen Preferred & Income Securities Fund(b)   12,000    109,680 
Royce Value Trust, Inc.   58,200    792,684 
Voya Global Equity Dividend and Premium Opportunity Fund(b)   61,700    403,518 
Wells Fargo Multi-Sector Income Fund(b)   17,800    213,778 
           
TOTAL CLOSED-END FUNDS          
(Cost $6,825,751)        6,863,962 
           
PREFERRED STOCKS 5.53%          
Annaly Capital Management, Inc.          
Series G, 6.500%(b)   60,000    1,429,800 
Ares Management Corp.          
Series A, 7.000%(b)   71,000    1,903,510 
First Republic Bank          
Series D, 5.500%(b)   2,464    57,608 
Global Medical REIT, Inc.          
Series A, 7.500%(b)   17,700    438,960 

 

   Shares   Value 
PREFERRED STOCKS (continued)          
PennyMac Mortgage Investment Trust          
Series A, 3M US L + 5.831%(b)(i)   48,692   $1,228,986 
Series B, 3M US L + 5.99%(b)(i)   10,000    249,400 
Summit Hotel Properties, Inc.          
Series E, 6.250%(b)   40,000    810,400 
Two Harbors Investment Corp.          
Series A, 3M US L + 5.66%(b)(i)   51,000    1,342,830 
Series C, 3M US L + 5.011%(b)(c)(i)   25,000    601,250 
           
TOTAL PREFERRED STOCKS          
(Cost $8,116,819)        8,062,744 

 

Description and

Maturity Date

 

Principal

Amount

   Value 
CORPORATE BONDS 0.67%          
Bank of America Corp.          
Series FF, Perpetual Maturity, 3M US L + 2.931%(b)(c)(i)(j)  $1,000,000    978,525 
           
TOTAL CORPORATE BONDS          
(Cost $997,500)        978,525 
           
GOVERNMENT & AGENCY OBLIGATIONS 6.96% 
U.S. Treasury Bonds          
08/15/2026, 6.750%(b)   1,000,000    1,288,184 
11/15/2026, 6.500%(b)   1,600,000    2,043,500 
08/15/2029, 6.125%(b)   2,000,000    2,635,312 
05/15/2044, 3.375%(b)   2,000,000    2,137,930 
05/15/2048, 3.125%(b)   2,000,000    2,045,820 
           
TOTAL GOVERNMENT & AGENCY OBLIGATIONS 
(Cost $10,378,801)        10,150,746 

 

  

Shares/Principal

Amount

   Value 
SHORT-TERM INVESTMENTS 10.13%      
Money Market Funds 6.08%      
BlackRock Liquidity Funds, T-Fund Portfolio - Institutional Class (2.243% 7-day yield)   8,870,727    8,870,727 
         8,870,727 
U.S. Treasury Bills 4.05%          
U.S. Treasury Bills          
07/18/2019, 2.488%(b)(k)  $2,000,000    1,977,745 
09/12/2019, 2.538%(b)(k)   2,000,000    1,970,298 
12/05/2019, 2.525%(b)(k)   2,000,000    1,958,282 
         5,906,325 
TOTAL SHORT-TERM INVESTMENTS 
(Cost $14,773,078)        14,777,052 


 

 

 

   Value 
Total Investments - 141.31%     
(Cost $198,721,435)  $206,191,376 
      
Liabilities in Excess of Other Assets - (41.31%)(l)   (60,276,894)
      
NET ASSETS - 100.00%  $145,914,482 

 

SCHEDULE OF SECURITIES SOLD SHORT (a)  Shares   Value 
COMMON STOCKS (8.38%)          
Consumer Staples (0.76%)          
Walgreens Boots Alliance, Inc.   (15,400)   (1,112,804)
           
Financials (3.95%)          
American Express Co.   (12,400)   (1,273,480)
Deutsche Bank AG   (159,100)   (1,412,808)
Mediobanca Banca di Credito Finanziario SpA   (161,400)   (1,403,275)
UniCredit SpA   (144,769)   (1,671,609)
         (5,761,172)
           
Health Care (3.30%)          
Alexion Pharmaceuticals, Inc.   (23,000)   (2,828,080)
Cardinal Health, Inc.   (24,600)   (1,229,262)
McKesson Corp.   (5,900)   (756,675)
         (4,814,017)
           
Industrials (0.37%)          
Stericycle, Inc.   (12,200)   (537,776)
           
TOTAL COMMON STOCKS          
(Proceeds $12,719,089)        (12,225,769)
           
EXCHANGE TRADED FUNDS (3.63%)     
Health Care Select Sector SPDR® Fund   (42,800)   (3,880,676)
iShares® Nasdaq Biotechnology ETF   (12,900)   (1,415,001)
           
           
TOTAL EXCHANGE TRADED FUNDS    
(Proceeds $4,682,210)        (5,295,677)
           
TOTAL SECURITIES SOLD SHORT      
(Proceeds $17,401,299)       $(17,521,446)

 

Investment Abbreviations:

1D FEDEF - Federal Funds Effective Rate (Daily)

LIBOR - London Interbank Offered Rate

 

Libor Rates:

3M US L - 3 Month LIBOR as of January 31, 2019 was 2.74%

 

(a)Non-income producing security.
(b)Pledged security; a portion or all of the security is pledged as collateral for securities sold short or borrowings. As of January 31, 2019, the aggregate value of those securities was $160,910,956, representing 110.28% of net assets. (See Note 1 and Note 2).
(c)Loaned security; a portion or all of the security is on loan as of January 31, 2019.
(d)Security filed for bankruptcy on November 26, 2018..
(e)Security exempt from registration of the Securities Act of 1933. These securities may be resold in transactions exempt from registration under Rule 144A, normally to qualified institutional buyers. As of January 31, 2019, these securities had an aggregate value of $2,202,432 or 1.51% of net assets. These securities have been deemed liquid by the Advisor based on procedures approved by the Board. (See Note 1)
(f)Private Placement; these securities may only be resold in transactions exempt from registration under the Securities Act of 1933. As of January 31, 2019, these securities had an aggregate value of $1,735,346 or 1.19% of net assets and have been deemed illiquid by the Adviser based on procedures approved by the Board. (See Note 1).
(g)Fair valued security; valued by management in accordance with procedures approved by the Board. As of January 31, 2019, these securities had an aggregate value of $1,735,346 or 1.19% of total net assets.
(h)As a result of the use of significant unobservable inputs to determine fair value, these investments have been classified as Level 3 assets. (See Note 1).
(i)Variable rate investment. Interest rates reset periodically. Interest rate shown reflects the rate in effect at January 31, 2019. For securities based on a published reference rate and spread, the reference rate and spread are indicated in the description above.
(j)This security has no contractual maturity date, is not redeemable and contractually pays an indefinite stream of interest.
(k)Rate shown represents the bond equivalent yield to maturity at date of purchase.
(l)Includes cash which is being held as collateral for total return swap contracts and securities sold short.


 

 

 

TOTAL RETURN SWAP CONTRACTS

 

Counter Party  Reference Entity/Obligation 

Notional

Amount

  

Floating Rate

Paid by the Fund

 

Floating

Rate Index

 

Termination

Date

  Value   Net Unrealized Appreciation 
Morgan Stanley  Banco Santander SA  $(1,380,869)  1D FEDEF - 50 bps  1 D FEDEF  05/20/2020  $(1,377,529)  $3,340 
Morgan Stanley  Kweichow Moutai Co., Ltd.   5,470,478   1D FEDEF + 250 BPS  1 D FEDEF  5/29/2020   5,842,497    372,019 
      $4,089,609            $4,464,968   $375,359 

 

Counter Party  Reference Entity/Obligation 

Notional

Amount

  

Floating Rate

Paid by the Fund

 

Floating

Rate Index

 

Termination

Date

  Value   Net Unrealized Depreciation 
Morgan Stanley  Jiangsu Yanghe Brewery Joint  $2,405,032   1D FEDEF + 255 bps  1 D FEDEF  10/01/2020  $2,051,928   $(353,104)
Morgan Stanley  Jiangsu Yanghe Brewery Joint   185,636   1D FEDEF + 250 bps  1 D FEDEF  5/29/2020   171,933    (13,703)
      $2,590,668            $2,223,861   $(366,807)
      $6,680,277            $6,688,829   $8,552 

 

 

Clough Global Opportunities Fund

STATEMENT OF INVESTMENTS

January 31, 2019 (Unaudited)

 

   Shares   Value 
COMMON STOCKS 103.01%
Communication Services 12.97%          
China Mobile, Ltd.   662,000   $6,942,979 
China Tower Corp., Ltd. - Class H(a)   7,060,000    1,511,478 
GCI Liberty, Inc. - Class A(a)(b)(c)   203,562    10,361,306 
Netflix, Inc.(a)(b)(c)   11,728    3,981,656 
Nintendo Co., Ltd.   9,375    2,911,694 
T-Mobile US, Inc.(a)(b)   215,900    15,030,958 
Zayo Group Holdings, Inc.(a)(b)   101,700    2,791,665 
         43,531,736 
           
Consumer Discretionary 13.21%          
Alibaba Group Holding, Ltd. - Sponsored ADR(a)(b)(c)   90,310    15,216,332 
Amazon.com, Inc.(a)(b)(c)   5,147    8,846,303 
Carvana Co.(a)(b)   103,720    3,853,198 
DR Horton, Inc.(b)(c)   149,601    5,752,159 
Lennar Corp. - Class A(b)(c)   156,200    7,407,004 
Pinduoduo, Inc. - ADR(a)(b)   112,000    3,271,520 
         44,346,516 
           
Energy 0.10%          
Fairway Energy LP(a)(d)(e)(f)(g)(h)   536,000    333,392 
           
Financials 27.59%          
Ares Capital Corp.(b)   619,100    10,091,330 
Bank of America Corp.(b)(c)   404,710    11,522,094 
Blackstone Mortgage Trust, Inc. - Class A(b)   364,700    12,578,503 
China Life Insurance Co., Ltd. - Class H   1,108,000    2,730,764 
Citigroup, Inc.(b)(c)   216,527    13,957,330 
Golub Capital BDC, Inc.(b)   313,957    5,739,134 
JPMorgan Chase & Co.(b)(c)   66,800    6,913,800 
Ladder Capital Corp.(b)   207,758    3,596,291 
Morgan Stanley   32,000    1,353,600 
Ping An Insurance Group Co. of China, Ltd. - Class H   216,700    2,095,988 
Solar Capital, Ltd.(b)   216,231    4,434,898 
Starwood Property Trust, Inc.(b)   628,986    13,888,011 
TPG Specialty Lending, Inc.(b)   186,183    3,692,009 
         92,593,752 
           
Health Care 18.25%          
Align Technology, Inc.(a)(b)(c)   12,405    3,088,225 
Amgen, Inc.(b)   21,450    4,013,509 
Anthem, Inc.(b)(c)   13,780    4,175,340 
Apellis Pharmaceuticals, Inc.(a)(b)(c)   214,401    3,001,614 
BeiGene, Ltd. - ADR(a)(b)(c)   16,300    2,110,524 
BioMarin Pharmaceutical, Inc.(a)(b)(c)   15,500    1,521,635 
Boston Scientific Corp.(a)(b)(c)   41,300    1,575,595 
   Shares   Value 
Health Care (continued)          
Centrexion Therapeutics(a)(e)(f)(g)(h)   1,361,111   $2,450,000 
Cigna Corp.(b)   13,705    2,738,396 
Correvio Pharma Corp.(a)   797,281    2,941,967 
CRISPR Therapeutics AG(a)(b)(c)   204,510    6,632,259 
Elanco Animal Health, Inc.(a)(b)   70,900    2,068,862 
Equillium, Inc.(a)(b)   89,200    784,068 
Gossamer Biosciences(a)(e)(f)(g)(h)   512,948    1,650,000 
GW Pharmaceuticals PLC - ADR(a)(b)(c)   11,810    1,685,878 
Humana, Inc.(b)(c)   11,200    3,460,688 
IDEXX Laboratories, Inc.(a)   7,000    1,489,460 
Illumina, Inc.(a)(b)   3,900    1,091,181 
Intra-Cellular Therapies, Inc.(a)(b)   51,574    620,951 
Johnson & Johnson(b)(c)   17,600    2,342,208 
Pfizer, Inc.(b)(c)   77,800    3,302,610 
UnitedHealth Group, Inc.(b)(c)   13,780    3,723,356 
Vertex Pharmaceuticals, Inc.(a)(b)(c)   9,820    1,874,736 
Zoetis, Inc.(b)   33,700    2,903,592 
         61,246,654 
           
Industrials 3.28%          
TransDigm Group, Inc.(a)(b)   28,130    10,998,830 
           
Information Technology 25.75%          
Broadcom, Ltd.(b)(c)   16,480    4,420,760 
Cypress Semiconductor Corp.   200,500    2,780,935 
Guidewire Software, Inc.(a)(b)(c)   30,600    2,652,408 
KLA-Tencor Corp.   26,400    2,813,448 
Lam Research Corp.   16,610    2,816,724 
Lumentum Holdings, Inc.(a)(b)(c)   88,365    4,321,932 
Marvell Technology Group, Ltd.   152,000    2,816,560 
Micron Technology, Inc.(a)(b)   186,600    7,131,852 
Microsoft Corp.(b)   44,450    4,641,914 
Mimecast, Ltd.(a)(b)(c)   104,330    3,919,678 
NXP Semiconductors NV   32,400    2,819,772 
Pluralsight, Inc. - Class A(a)(b)   79,200    2,374,416 
Proofpoint, Inc.(a)(b)   16,000    1,629,920 
RingCentral, Inc. - Class A(a)(b)(c)   24,700    2,283,268 
salesforce.com, Inc.(a)(b)(c)   56,340    8,561,990 
Samsung Electronics Co., Ltd.   337,357    13,992,743 
ServiceNow, Inc.(a)(b)(c)   11,710    2,576,434 
Visa, Inc. - Class A(b)   51,700    6,980,017 
WNS Holdings, Ltd. - ADR(a)(b)(c)   85,147    4,154,322 
Xilinx, Inc.(b)(c)   24,400    2,731,336 
         86,420,429 
           
Real Estate 1.86%          
SBA Communications Corp.(a)(b)(c)   34,100    6,224,273 
           
TOTAL COMMON STOCKS          
(Cost $335,494,512)        345,695,582 

 

 

         
   Shares   Value 
CLOSED-END FUNDS 1.91%          
Aberdeen Total Dynamic Dividend Fund(b)   88,600   $724,748 
Advent Claymore Convertible Securities and Income Fund(b)   12,000    169,680 
Blackstone / GSO Strategic Credit Fund(b)   15,200    218,272 
Cornerstone Strategic Value Fund, Inc.(b)   191,400    2,325,510 
Cornerstone Total Return Fund, Inc.(b)   197,900    2,339,178 
Royce Value Trust, Inc.(b)   46,800    637,416 
           
TOTAL CLOSED-END FUNDS          
(Cost $6,300,041)        6,414,804 
           
PREFERRED STOCKS 5.09%          
Annaly Capital Management, Inc.          
Series G, 6.500%(b)   65,000    1,548,950 
Ares Management Corp.          
Series A, 7.000%(b)   147,000    3,941,070 
M&T Bank Corp.          
Series A, 6.375%(b)   3,000    3,000,000 
PennyMac Mortgage Investment Trust          
Series B, 3M US L + 5.99%(b)(i)   70,000    1,745,800 
Summit Hotel Properties, Inc.          
Series E, 6.250%(b)   116,000    2,350,160 
Two Harbors Investment Corp.          
Series A, 3M US L + 5.66%(b)(i)   75,000    1,974,750 
Series C, 3M US L + 5.011%(b)(c)(i)   105,000    2,525,250 
           
TOTAL PREFERRED STOCKS          
(Cost $17,493,550)        17,085,980 

 

Description and  Principal     
Maturity Date   Amount   Value 
CORPORATE BONDS 14.12%           
Ares Capital Corp.           
02/10/2023, 3.500%(b)   $1,000,000    952,777 
Bank of America Corp.           
Series V, Perpetual Maturity, 3M US L + 3.387%(b)(c)(i)(j)    5,000,000    4,982,375 
Citizens Financial Group, Inc.           
Series B, Perpetual Maturity, 3M US L + 3.003%(b)(c)(i)(j)    2,000,000    1,905,450 
Comcast Corp.           
07/15/2046, 3.400%(b)    3,000,000    2,573,724 
Fifth Third Bancorp           
Perpetual Maturity, 3M US L + 3.0333%(b)(i)    2,000,000    1,880,450 
Series J, Perpetual Maturity, 3M US L + 3.129%(b)(c)(i)(j)    4,000,000    3,940,000 
Hercules Capital, Inc.           
10/23/2022, 4.625%(b)(c)    3,000,000    2,887,777 
Description and  Principal     
Maturity Date  Amount   Value 
CORPORATE BONDS (continued)          
JPMorgan Chase & Co.          
Series Z, Perpetual Maturity, 3M US L + 3.80%(b)(c)(i)(j)  $4,750,000   $4,822,889 
Main Street Capital Corp.          
12/01/2022, 4.500%(b)(c)   3,750,000    3,780,537 
Metropolitan Life Global Funding I          
01/11/2024, 3.600%(b)(e)   2,800,000    2,837,634 
NextEra Energy Capital Holdings, Inc.          
10/01/2066, 3M US L + 2.0675%(i)   2,500,000    2,187,962 
People's United Bank National Association          
07/15/2024, 4.000%(b)   2,200,000    2,197,123 
Solar Capital, Ltd.          
01/20/2023, 4.500%(b)   2,500,000    2,364,164 
SVB Financial Group          
01/29/2025, 3.500%   2,000,000    1,938,916 
Towne Bank/Portsmouth VA          
07/30/2027, 3M US L + 2.55%(b)(i)   2,400,000    2,390,855 
TPG Specialty Lending, Inc.          
01/22/2023, 4.500%(b)(c)   4,250,000    4,205,254 
Welltower, Inc.          
04/01/2019, 4.125%(b)   33,000    33,026 
04/01/2026, 4.250%(b)   1,500,000    1,513,786 
           
TOTAL CORPORATE BONDS          
(Cost $48,020,548)        47,394,699 
           
GOVERNMENT & AGENCY OBLIGATIONS 14.33%          
U.S. Treasury Bonds          
08/15/2026, 6.750%(b)   4,250,000    5,474,780 
11/15/2026, 6.500%(b)   3,150,000    4,023,141 
08/15/2029, 6.125%(b)   3,375,000    4,447,090 
02/15/2038, 4.375%(b)   4,000,000    4,929,375 
05/15/2040, 4.375%(b)   3,000,000    3,703,945 
02/15/2041, 4.750%(b)   3,000,000    3,893,789 
05/15/2041, 4.375%(b)   3,000,000    3,709,336 
08/15/2043, 3.625%(b)   4,000,000    4,447,422 
05/15/2048, 3.125%(b)   10,000,000    10,229,101 
11/15/2048, 3.375%   3,000,000    3,220,254 
           
TOTAL GOVERNMENT & AGENCY OBLIGATIONS          
(Cost $48,042,619)        48,078,233 

 

   Shares/Principal Amount   Value 
SHORT-TERM INVESTMENTS 6.06%
Money Market Funds  6.06%          
BlackRock Liquidity Funds, T-Fund Portfolio - Institutional Class (2.243% 7-day yield)   20,335,321    20,335,321 
         20,335,321 
TOTAL SHORT-TERM INVESTMENTS          
(Cost $20,335,321)        20,335,321 

 

 

   Value 
Total Investments - 144.52%     
(Cost $475,686,591)  $485,004,619 
      
Liabilities in Excess of Other Assets - (44.52%)(k)   (149,418,337)
      
NET ASSETS - 100.00%  $335,586,282 
      

 

SCHEDULE OF SECURITIES SOLD SHORT (a)  Shares   Value 
COMMON STOCKS (8.54%)
Consumer Staples (0.78%)          
Walgreens Boots Alliance, Inc.   (36,500)   (2,637,490)
           
Financials (4.01%)          
American Express Co.   (28,600)   (2,937,220)
Deutsche Bank AG   (371,400)   (3,298,032)
Mediobanca Banca di Credito Finanziario SpA   (378,800)   (3,293,434)
UniCredit SpA   (339,568)   (3,920,901)
         (13,449,587)
           
Health Care (3.38%)          
Alexion Pharmaceuticals, Inc.   (54,300)   (6,676,728)
Cardinal Health, Inc.   (58,400)   (2,918,248)
McKesson Corp.   (13,530)   (1,735,223)
         (11,330,199)
           
Industrials (0.37%)          
Stericycle, Inc.   (28,500)   (1,256,280)
           
TOTAL COMMON STOCKS          
(Proceeds $29,809,479)        (28,673,556)
           
EXCHANGE TRADED FUNDS (2.84%)          
Health Care Select Sector SPDR® Fund   (67,700)   (6,138,359)
iShares® Nasdaq Biotechnology ETF   (30,800)   (3,378,452)
           
TOTAL EXCHANGE TRADED FUNDS          
(Proceeds $8,351,194)        (9,516,811)
           
TOTAL SECURITIES SOLD SHORT          
(Proceeds $38,160,673)       $(38,190,367)

 

Investment Abbreviations:
1D FEDEF - Federal Funds Effective Rate (Daily)
LIBOR - London Interbank Offered Rate
 
Libor Rates:
3M US L - 3 Month LIBOR as of January 31, 2019 was 2.74%

 

(a) Non-income producing security.
(b) Pledged security; a portion or all of the security is pledged as collateral for securities sold short or borrowings. As of January 31, 2019, the aggregate value of those securities was $361,296,189, representing 107.66% of net assets. (See Note 1 and Note 2).
(c) Loaned security; a portion or all of the security is on loan as of January 31, 2019.
(d) Security filed for bankruptcy on November 26, 2018..
(e) Security exempt from registration of the Securities Act of 1933.  These securities may be resold in transactions exempt from registration under Rule 144A, normally to qualified institutional buyers. As of January 31, 2019, these securities had an aggregate value of $7,271,026 or 2.17% of net assets.  These securities have been deemed liquid by the Advisor based on procedures approved by the Board.  (See Note 1)
(f) Private Placement; these securities may only be resold in transactions exempt from registration under the Securities Act of 1933. As of January 31, 2019, these securities had an aggregate value of $4,433,392 or 1.32% of net assets and have been deemed illiquid by the Adviser based on procedures approved by the Board. (See Note 1).
(g) Fair valued security; valued by management in accordance with procedures approved by the Board. As of January 31, 2019, these securities had an aggregate value of $4,433,392 or 1.32% of total net assets.
(h) As a result of the use of significant unobservable inputs to determine fair value, these investments have been classified as Level 3 assets. (See Note 1).
(i) Variable rate investment. Interest rates reset periodically. Interest rate shown reflects the rate in effect at January 31, 2019. For securities based on a published reference rate and spread, the reference rate and spread are indicated in the description above.
(j) This security has no contractual maturity date, is not redeemable and contractually pays an indefinite stream of interest.
(k) Includes cash which is being held as collateral for total return swap contracts and securities sold short.

 

 

TOTAL RETURN SWAP CONTRACTS        
         
   Reference  Notional   Floating Rate  Floating  Termination        Net Unrealized 
Counter Party  Entity/Obligation  Amount   Paid by the Fund  Rate Index   Date   Value   Appreciation 
Morgan Stanley  Banco Santander SA  $(3,230,001)  1D FEDEF - 50 bps  1 D FEDEF   05/20/2020   $(3,222,300)  $7,701 
Morgan Stanley  Kweichow Moutai Co., Ltd.   12,612,145   1D FEDEF + 250 BPS  1 D FEDEF   5/29/2020    13,471,136    858,991 
      $9,382,144              $10,248,836   $866,692 

 

   Reference  Notional   Floating Rate  Floating  Termination       Net Unrealized 
Counter Party  Entity/Obligation  Amount   Paid by the Fund  Rate Index  Date   Value   Depreciation 
Morgan Stanley  Jiangsu Yanghe Brewery Joint  $5,644,976   1D FEDEF + 255 bps  1 D FEDEF   10/01/2020   $4,819,888   $(825,088)
Morgan Stanley  Jiangsu Yanghe Brewery Joint   432,883   1D FEDEF + 250 bps  1 D FEDEF   5/29/2020    400,929    (31,954)
      $6,077,859              $5,220,817   $(857,042)
      $15,460,003              $15,469,653   $9,650 

 

For Fund compliance purposes, the Fund’s sector classifications refer to any one of the sector sub-classifications used by one or more widely recognized market indexes, and/or as defined by Fund management. This definition may not apply for purposes of this report, which may combine sector sub-classifications for reporting ease. Sectors are shown as a percent of net assets. These sector classifications are unaudited.

 
See Notes to Quarterly Statement of Investments.

 

 

 

Clough Global FundS

Notes to Quarterly Statement of Investments

January 31, 2019 (unaudited)

 

1. Organization and SIGNIFICANT ACCOUNTING AND OPERATING POLICIES

 

 

Clough Global Dividend and Income Fund, Clough Global Equity Fund, and Clough Global Opportunities Fund (each a “Fund”, collectively the “Funds”), are closed-end management investment companies registered under the Investment Company Act of 1940 (the “1940 Act”). The Funds were organized under the laws of the state of Delaware on April 27, 2004, January 25, 2005, and January 12, 2006, respectively for Clough Global Dividend and Income Fund, Clough Global Equity Fund, and Clough Global Opportunities Fund. The Funds were previously registered as non-diversified investment companies. As a result of ongoing operations, each of the Funds became a diversified company. The Funds may not resume operating in a non-diversified manner without first obtaining shareholder approval. Each Fund’s investment objective is to provide a high level of total return. Each Declaration of Trust provides that the Board of Trustees (the “Board”) may authorize separate classes of shares of beneficial interest. The common shares of Clough Global Dividend and Income Fund, Clough Global Equity Fund, and Clough Global Opportunities Fund are listed on the NYSE American LLC and trade under the ticker symbols “GLV”, “GLQ” and “GLO” respectively.

 

The following is a summary of significant accounting policies followed by the Funds. These policies are in conformity with U.S. generally accepted accounting principles (“GAAP”). The preparation of the Statement of Investments in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts and disclosures in the Statement of Investments during the reporting period. Management believes the estimates and security valuations are appropriate; however, actual results may differ from those estimates, and the security valuations reflected in the Statement of Investments may differ from the value the Funds ultimately realize upon sale of the securities. Each Fund is considered an investment company for financial reporting purposes under GAAP and follows the accounting and reporting guidance applicable to investment companies as codified in Accounting Standards Codification Topic (“ASC”) 946 – Investment Companies.

 

The net asset value per share of each Fund is determined no less frequently than daily, on each day that the New York Stock Exchange (“NYSE” or the “Exchange”) is open for trading, as of the close of regular trading on the Exchange (normally 4:00 p.m. New York time). Trading may take place in foreign issues held by the Fund at times when a Fund is not open for business. As a result, each Fund’s net asset value may change at times when it is not possible to purchase or sell shares of a Fund.

 

Investment Valuation: Securities, including preferred stocks, exchange traded funds, closed-end funds and participation notes held by each Fund for which exchange quotations are readily available are valued at the last sale price, or if no sale price or if traded on the over-the-counter market, at the mean of the bid and asked prices on such day. Most securities listed on a foreign exchange are valued at the last sale price at the close of the exchange on which the security is primarily traded. In certain countries market maker prices are used since they are the most representative of the daily trading activity. Market maker prices are usually the mean between the bid and ask prices. Certain markets are not closed at the time that the Funds price their portfolio securities. In these situations, snapshot prices are provided by the individual pricing services or other alternate sources at the close of the NYSE as appropriate. Securities not traded on a particular day are valued at the mean between the last reported bid and the asked quotes, or the last sale price when appropriate; otherwise fair value will be determined by the board-appointed fair valuation committee. Debt securities for which the over-the-counter market is the primary market are normally valued on the basis of prices furnished by one or more pricing services or dealers at the mean between the latest available bid and asked prices. As authorized by the Board, debt securities (including short-term obligations that will mature in 60 days or less) may be valued on the basis of valuations furnished by a pricing service which determines valuations based upon market transactions for normal, institutional-size trading units of securities or a matrix method which considers yield or price of comparable bonds provided by a pricing service. Over-the-counter options are valued at the mean between bid and asked prices provided by dealers. Exchange-traded options are valued at closing settlement prices. Total return swaps are priced based on valuations provided by a Board approved independent third party pricing agent. If a total return swap price cannot be obtained from an independent third party pricing agent the Fund shall seek to obtain a bid price from at least one independent and/or executing broker.

 

If the price of a security is unavailable in accordance with the aforementioned pricing procedures, or the price of a security is unreliable, e.g., due to the occurrence of a significant event, the security may be valued at its fair value determined by management pursuant to procedures adopted by the Board. For this purpose, fair value is the price that a Fund reasonably expects to receive on a current sale of the security. Due to the number of variables affecting the price of a security, however; it is possible that the fair value of a security may not accurately reflect the price that a Fund could actually receive on a sale of the security.

 

A three-tier hierarchy has been established to classify fair value measurements for disclosure purposes. Inputs refer broadly to the assumptions that market participants would use in pricing the asset or liability, including assumptions about risk. Inputs may be observable or unobservable. Observable inputs are inputs that reflect the assumptions market participants would use in pricing the asset or liability that are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs are inputs that reflect the reporting entity’s own assumptions about the assumptions market participants would use in pricing the asset or liability that are developed based on the best information available.

 

 

 

Various inputs are used in determining the value of each Fund’s investments as of the reporting period end. These inputs are categorized in the following hierarchy under applicable financial accounting standards:

 

Level 1 – Unadjusted quoted prices in active markets for identical, unrestricted assets or liabilities that a Fund has the ability to access at the measurement date;
Level 2 – Quoted prices which are not active, quoted prices for similar assets or liabilities in active markets or inputs other than quoted prices that are observable (either directly or indirectly) for substantially the full term of the asset or liability; and
Level 3 – Significant unobservable prices or inputs (including the Fund’s own assumptions in determining the fair value of investments) where there is little or no market activity for the asset or liability at the measurement date.

 

The following is a summary of the inputs used as of January 31, 2019, in valuing each Fund’s investments carried at value.

 

Clough Global Dividend and Income Fund

 

Investments in Securities at Value*  Level 1  Level 2  Level 3  Total
Common Stocks                    
Communication Services  $3,999,827   $   $   $3,999,827 
Consumer Discretionary   3,290,204            3,290,204 
Energy           81,296    81,296 
Financials   27,797,759            27,797,759 
Health Care   10,196,764            10,196,764 
Information Technology   16,238,236            16,238,236 
Real Estate   5,536,820            5,536,820 
Closed-End Funds   3,169,148            3,169,148 
Preferred Stocks   7,997,692            7,997,692 
Corporate Bonds       16,426,402        16,426,402 
Asset/Mortgage Backed Securities       94,585        94,585 
Government & Agency Obligations       20,531,397        20,531,397 
Short-Term Investments                    
Money Market Funds   2,678,126            2,678,126 
TOTAL  $80,904,576   $37,052,384   $81,296   $118,038,256 

 

Other Financial Instruments  Level 1   Level 2   Level 3   Total 
Assets                    
Total Return Swap Contracts**  $   $223,281   $   $223,281 
                     
Liabilities                    
Securities Sold Short                    
Common Stocks   (7,212,151)           (7,212,151)
Exchange Traded Funds   (899,458)           (899,458)
Total Return Swap Contracts**       (297,101)       (297,101)
TOTAL  $(8,111,609)  $(73,820)  $   $(8,185,429)

 

Clough Global Equity Fund

 

Investments in Securities at Value*  Level 1   Level 2   Level 3   Total 
Common Stocks                    
Communication Services  $18,679,443   $   $   $18,679,443 
Consumer Discretionary   19,105,867            19,105,867 
Energy           135,347    135,347 
Financials   46,916,479            46,916,479 
Health Care   31,129,059        1,599,999    32,729,058 
Industrials   4,748,695            4,748,695 
Information Technology   38,884,457            38,884,457 
Real Estate   4,159,001            4,159,001 
Closed-End Funds   6,863,962            6,863,962 
Preferred Stocks   8,062,744            8,062,744 
Corporate Bonds       978,525        978,525 
Government & Agency Obligations       10,150,746        10,150,746 
Short-Term Investments                    
Money Market Funds   8,870,727            8,870,727 
U.S. Treasury Bills       5,906,325        5,906,325 
TOTAL  $187,420,434   $17,035,596   $1,735,346   $206,191,376 

 

 

 

Other Financial Instruments  Level 1   Level 2   Level 3   Total 
Assets                    
Total Return Swap Contracts**  $   $375,359   $   $375,359 
                     
Liabilities                    
Securities Sold Short                    
Common Stocks   (12,225,769)           (12,225,769)
Exchange Traded Funds   (5,295,677)           (5,295,677)
Total Return Swap Contracts**       (366,807)       (366,807)
TOTAL  $(17,521,446)  $8,552   $   $(17,512,894)

 

Clough Global Opportunities Fund

 

Investments in Securities at Value*  Level 1   Level 2   Level 3   Total 
Common Stocks                    
Communication Services  $43,531,736   $   $   $43,531,736 
Consumer Discretionary   44,346,516            44,346,516 
Energy           333,392    333,392 
Financials   92,593,752            92,593,752 
Health Care   57,146,654        4,100,000    61,246,654 
Industrials   10,998,830            10,998,830 
Information Technology   86,420,429            86,420,429 
Real Estate   6,224,273            6,224,273 
Closed-End Funds   6,414,804            6,414,804 
Preferred Stocks   17,085,980            17,085,980 
Corporate Bonds       47,394,699        47,394,699 
Government & Agency Obligations       48,078,233        48,078,233 
Short-Term Investments                    
Money Market Funds   20,335,321            20,335,321 
TOTAL  $385,098,294   $95,472,933   $4,433,392   $485,004,619 

 

Other Financial Instruments  Level 1   Level 2   Level 3   Total 
Assets                    
Total Return Swap Contracts**  $   $866,692   $   $866,692 
                     
Liabilities                    
Securities Sold Short                    
Common Stocks   (28,673,556)           (28,673,556)
Exchange Traded Funds   (9,516,811)           (9,516,811)
Total Return Swap Contracts**       (857,042)       (857,042)
TOTAL  $(38,190,367)  $9,650   $   $(38,180,717)

 

*For detailed sector descriptions, see the accompanying Statements of Investments.
**Swap contracts are reported at their unrealized appreciation/(depreciation) at measurement date, which represents the change in the contract's value from trade date.

                                 

In the event a Board approved independent pricing service is unable to provide an evaluated price for a security or Clough Capital Partners L.P. (the “Adviser” or “Clough”) believes the price provided is not reliable, securities of each Fund may be valued at fair value as described above. In these instances the Adviser may seek to find an alternative independent source, such as a broker/dealer to provide a price quote, or by using evaluated pricing models similar to the techniques and models used by the independent pricing service. These fair value measurement techniques may utilize unobservable inputs (Level 3).

 

On a monthly basis, the Fair Value Committee of each Fund meets and discusses securities that have been fair valued during the preceding month in accordance with the Funds’ Fair Value Procedures and reports quarterly to the Board on the results of those meetings.

 

 

 

The following is a reconciliation of the investments in which significant unobservable inputs (Level 3) were used in determining fair value:

 

Clough Global Dividend and Income Fund

 

Investments in

Securities

 

Balance as of

October 31,

2018

 

Realized

Gain/(Loss)

 

Change in Unrealized

Appreciation/

(Depreciation)

  Purchases  Sales Proceeds 

Transfer

into

Level 3

 

Transfer

out of

Level 3

 

Balance as of January 31,

2019

 

Net change in

unrealized

appreciation/

(depreciation) attributable to Level 3

investments held at

January 31, 2019

Common Stocks  $264,929   $   $(183,633)  $   $   $   $   $81,296   $(183,633)
Total  $264,929   $   $(183,633)  $   $   $   $   $81.296   $(183,633)

 

Clough Global Equity Fund

 

Investments in

Securities

 

Balance as of

October 31,

2018

 

Realized

Gain/(Loss)

 

Change in Unrealized

Appreciation/

(Depreciation)

  Purchases  Sales Proceeds 

Transfer

into

Level 3

Transfer

out of

Level 3

 

Balance as of January 31,

2019

 

Net change in

unrealized

appreciation/

(depreciation)

attributable to Level 3

investments held at

January 31, 2019

Common Stocks  $2,041,074   $   $(305,728)  $   $   $     $   $1,735,346   $(305,728)
Total  $2,041,074   $   $(305,728)  $   $   $     $   $1,735,346   $(305,728)

 

Clough Global Opportunities Fund

 

Investments in

Securities

 

Balance as of

October 31,

2018

 

Realized

Gain/(Loss)

 

Change in Unrealized

Appreciation/

(Depreciation)

  Purchases  Sales Proceeds 

Transfer

into

Level 3

 

Transfer

out of

Level 3

 

Balance as of January 31,

2019

 

Net change in

unrealized

appreciation/

(depreciation)

attributable to Level 3

investments held at

January 31, 2019

Common Stocks  $5,186,472   $   $(753,080)  $   $   $   $   $4,433,392   $(753,080)
Total  $5,186,472   $   $(753,080)  $   $   $   $   $4,433,392   $(753,080)

 

The following is a summary of valuation techniques and quantitative information used in determining the fair value of the Fund’s Level 3 investments at January 31, 2019:

 

Fund Sector Fair Value Valuation Technique Unobservable Input(b) Range/Premium
Clough Global Dividend and Income Fund Energy $81,296 Net Asset Value(a) Adjusted Net Asset Value 0.00x – 1.23x
Clough Global Equity Fund Energy $135,347 Net Asset Value(a) Adjusted Net Asset Value 0.00x – 1.23x
  Health Care $1,599,999 Recent Financings Transaction Price N/A
Clough Global Opportunities Fund Energy $333,392 Net Asset Value(a) Adjusted Net Asset Value 0.00x – 1.23x
  Health Care $4,100,000 Recent Financings Transaction Price N/A

 

(a)Due to bankruptcy filing by security, the valuation technique has changed.
(b)A change to the unobservable input may result in a significant change to the value of the investment as follows:

 

Unobservable Input Impact to Value if Input Increases Impact to Value if Input Decreases
Adjusted Net Asset Value Increase Decrease
Transaction Price Increase Decrease

 

Foreign Securities: Each Fund may invest a portion of its assets in foreign securities. In the event that a Fund executes a foreign security transaction, the Fund will generally enter into a foreign currency spot contract to settle the foreign security transaction. Foreign securities may carry more risk than U.S. securities, such as political, market and currency risks.

 

 

 

The accounting records of each Fund are maintained in U.S. dollars. Prices of securities denominated in foreign currencies are translated into U.S. dollars at the closing rates of exchange at period end. Amounts related to the purchase and sale of foreign securities and investment income are translated at the rates of exchange prevailing on the respective dates of such transactions.

 

A foreign currency spot contract is a commitment to purchase or sell a foreign currency at a future date, at a negotiated rate. Each Fund may enter into foreign currency spot contracts to settle specific purchases or sales of securities denominated in a foreign currency and for protection from adverse exchange rate fluctuation. Risks to a Fund include the potential inability of the counterparty to meet the terms of the contract.

 

Exchange Traded Funds: Each Fund may invest in exchange traded funds (“ETFs”), which are funds whose shares are traded on a national exchange. ETFs may be based on underlying equity or fixed income securities, as well as commodities or currencies. ETFs do not sell individual shares directly to investors and only issue their shares in large blocks known as “creation units.” The investor purchasing a creation unit then sells the individual shares on a secondary market. Although similar diversification benefits may be achieved through an investment in another investment company, ETFs generally offer greater liquidity and lower expenses. Because an ETF incurs its own fees and expenses, shareholders of a Fund investing in an ETF will indirectly bear those costs. Such Funds will also incur brokerage commissions and related charges when purchasing or selling shares of an ETF. Unlike typical investment company shares, which are valued once daily, shares in an ETF may be purchased or sold on a securities exchange throughout the trading day at market prices that are generally close to the NAV of the ETF.

 

Short Sales: Each Fund may sell a security it does not own in anticipation of a decline in the fair value of that security. When a Fund sells a security short, it must borrow the security sold short and deliver it to the broker-dealer through which it made the short sale. A gain, limited to the price at which a Fund sold the security short, or a loss, unlimited in size, will be recognized upon the termination of the short sale.

 

Each Fund's obligation to replace the borrowed security will be secured by collateral deposited with the broker-dealer, usually cash, U.S. government securities or other liquid securities. Each Fund will also be required to designate on its books and records similar collateral with its custodian to the extent, if any, necessary so that the aggregate collateral value is at all times at least equal to the current value of the security sold short. Each Fund is obligated to pay interest to the broker for any debit balance of the margin account relating to short sales.

 

Each Fund may also sell a security short if it owns at least an equal amount of the security sold short or another security convertible or exchangeable for an equal amount of the security sold short without payment of further compensation (a short sale against-the-box). In a short sale against-the-box, the short seller is exposed to the risk of being forced to deliver stock that it holds to close the position if the borrowed stock is called in by the lender, which would cause gain or loss to be recognized on the delivered stock. Each Fund expects normally to close its short sales against-the-box by delivering newly acquired stock.

 

Derivatives Instruments and Hedging Activities: The following discloses the Funds’ use of derivative instruments and hedging activities.

 

The Funds’ investment objectives not only permit the Funds to purchase investment securities, they also allow the Funds to enter into various types of derivative contracts, including, but not limited to, purchased and written options, swaps, futures and warrants. In doing so, the Funds will employ strategies in differing combinations to permit them to increase, decrease, or change the level or types of exposure to market factors. Central to those strategies are features inherent to derivatives that make them more attractive for this purpose than equity securities; they require little or no initial cash investment, they can focus exposure on only certain selected risk factors, and they may not require the ultimate receipt or delivery of the underlying security (or securities) to the contract. This may allow the Funds to pursue their objectives more quickly and efficiently than if they were to make direct purchases or sales of securities capable of affecting a similar response to market factors.

 

Risk of Investing in Derivatives: The Funds’ use of derivatives can result in losses due to unanticipated changes in the market risk factors and the overall market. In instances where the Funds are using derivatives to decrease or hedge exposures to market risk factors for securities held by the Funds, there are also risks that those derivatives may not perform as expected, resulting in losses for the combined or hedged positions.

 

Derivatives may have little or no initial cash investment relative to their market value exposure and therefore can produce significant gains or losses in excess of their cost. This use of embedded leverage allows the Funds to increase their market value exposure relative to their net assets and can substantially increase the volatility of the Funds’ performance.

 

Additional associated risks from investing in derivatives also exist and potentially could have significant effects on the valuation of the derivative and the Funds. Typically, the associated risks are not the risks that the Funds are attempting to increase or decrease exposure to, per their investment objectives, but are the additional risks from investing in derivatives.

 

Examples of these associated risks are liquidity risk, which is the risk that the Funds will not be able to sell the derivative in the open market in a timely manner, and counterparty credit risk, which is the risk that the counterparty will not fulfill its obligation to the Funds. Associated risks can be different for each type of derivative and are discussed by each derivative type in the notes that follow.

 

 

Each Fund may acquire put and call options and options on stock indices and enter into stock index futures contracts, certain credit derivatives transactions and short sales in connection with its equity investments. In connection with a Fund's investments in debt securities, it may enter into related derivatives transactions such as interest rate futures, swaps and options thereon and certain credit derivatives transactions. Derivatives transactions of the types described above subject a Fund to increased risk of principal loss due to imperfect correlation or unexpected price or interest rate movements. Each Fund also will be subject to credit risk with respect to the counterparties to the derivatives contracts purchased by a Fund. If a counterparty becomes bankrupt or otherwise fails to perform its obligations under a derivatives contract due to financial difficulties, each Fund may experience significant delays in obtaining any recovery under the derivatives contract in a bankruptcy or other reorganization proceeding. Each Fund may obtain only a limited recovery or may obtain no recovery in such circumstances.

 

Market Risk Factors: In addition, in pursuit of their investment objectives, certain Funds may seek to use derivatives, which may increase or decrease exposure to the following market risk factors:

 

Equity Risk: Equity risk relates to the change in value of equity securities as they relate to increases or decreases in the general market.

 

Foreign Exchange Rate Risk: Foreign exchange rate risk relates to the change in the U.S. dollar value of a security held that is denominated in a foreign currency. The value of a foreign currency denominated security will decrease as the dollar appreciates against the currency, while the value of the foreign currency denominated security will increase as the dollar depreciates against the currency.

 

Option Writing/Purchasing: Each Fund may purchase or write (sell) put and call options. One of the risks associated with purchasing an option among others, is that a Fund pays a premium whether or not the option is exercised. Additionally, a Fund bears the risk of loss of premium and change in value should the counterparty not perform under the contract. The cost of securities acquired through the exercise of call options is increased by premiums paid. The proceeds from securities sold through the exercise of put options are decreased by the premiums paid. Each Fund is obligated to pay interest to the broker for any debit balance of the margin account relating to options. Each Fund pledges cash or liquid assets as collateral to satisfy the current obligations with respect to written options.

 

When a Fund writes an option, an amount equal to the premium received by a Fund is recorded as a liability and is subsequently adjusted to the current value of the option written. Premiums received from writing options that expire unexercised are treated by a Fund on the expiration date as realized gains. The difference between the premium received and the amount paid on effecting a closing purchase transaction, including brokerage commissions, is recorded as a realized gain or loss. If a call option is exercised, the premium is added to the proceeds from the sale of the underlying security or currency in determining whether a Fund has realized a gain or loss. If a put option is exercised, the premium reduces the cost basis of the securities purchased by a Fund. Each Fund, as writer of an option, bears the market risk of an unfavorable change in the price of the security underlying the written option.

 

There was no written option or purchased option activity for the period ended January 31, 2019.

 

Futures Contracts: Each Fund may enter into futures contracts. A futures contract is an agreement to buy or sell a security or currency (or to deliver a final cash settlement price in the case of a contract relating to an index or otherwise not calling for physical delivery at the end of trading in the contract) for a set price at a future date. If a Fund buys a security futures contract, the Fund enters into a contract to purchase the underlying security and is said to be "long" under the contract. If a Fund sells a security futures contact, the Fund enters into a contract to sell the underlying security and is said to be "short" under the contract. The price at which the contract trades (the "contract price") is determined by relative buying and selling interest on a regulated exchange. Futures contracts are marked to market daily and an appropriate payable or receivable for the change in value (“variation margin”) is recorded by the Fund. Such payables or receivables are recorded for financial statement purposes as variation margin payable or variation margin receivable by each Fund. Each Fund pledges cash or liquid assets as collateral to satisfy the current obligations with respect to futures contracts. Management has reviewed the futures agreement under which the futures contracts are traded and has determined that the Funds do not have the right to set-off, and therefore the futures contracts are not subject to enforceable
netting arrangements.

 

The Funds enter into such transactions for hedging and other appropriate risk-management purposes or to increase return. While a Fund may enter into futures contracts for hedging purposes, the use of futures contracts might result in a poorer overall performance for the Fund than if it had not engaged in any such transactions. If, for example, the Fund had insufficient cash, it might have to sell a portion of its underlying portfolio of securities in order to meet daily variation margin requirements on its futures contracts or options on futures contracts at a time when it might be disadvantageous to do so. There may be an imperfect correlation between the Funds’ portfolio holdings and futures contracts entered into by the Fund, which may prevent the Fund from achieving the intended hedge or expose the Fund to risk of loss.

 

Futures contract transactions may result in losses substantially in excess of the variation margin. There can be no guarantee that there will be a correlation between price movements in the hedging vehicle and in the portfolio securities being hedged. An incorrect correlation could result in a loss on both the hedged securities in a Fund and the hedging vehicle so that the portfolio return might have been greater had hedging not been attempted. There can be no assurance that a liquid market will exist at a time when the Fund seeks to close out a futures contract. Lack of a liquid market for any reason may prevent a Fund from liquidating an unfavorable position, and the Fund would remain obligated to meet margin requirements until the position is closed. In addition, the Fund could be exposed to risk if the counterparties to the contracts are unable to meet the terms of their contracts. With exchange-traded futures contracts, there is minimal counterparty credit risk to the Funds since futures contracts are exchange-traded and the exchange’s clearinghouse, as counterparty to all exchange-traded futures contracts, guarantees the futures contracts against default.

 

 

Each Fund held no futures contracts at the end of the period.

 

Swaps: During the period each Fund engaged in total return swaps. A swap is an agreement that obligates two parties to exchange a series of cash flows at specified intervals based upon or calculated by reference to changes in specified prices or rates for a specified amount of an underlying asset. Each Fund may utilize swap agreements as a means to gain exposure to certain assets and/or to “hedge” or protect the Fund from adverse movements in securities prices or interest rates. Each Fund is subject to equity risk and interest rate risk in the normal course of pursuing its investment objective through investments in swap contracts. Swap agreements entail the risk that a party will default on its payment obligation to a Fund. If the other party to a swap defaults, a Fund would risk the loss of the net amount of the payments that it contractually is entitled to receive. If each Fund utilizes a swap at the wrong time or judges market conditions incorrectly, the swap may result in a loss to the Fund and reduce the Fund’s total return.

 

Total return swaps involve an exchange by two parties in which one party makes payments based on a set rate, either fixed or variable, while the other party makes payments based on the return of an underlying asset, which includes both the income it generates and any capital gains over the payment period. A Fund’s maximum risk of loss from counterparty risk or credit risk is the discounted value of the payments to be received from/paid to the counterparty over the contract’s remaining life, to the extent that the amount is positive. The risk is mitigated by having a netting arrangement between a Fund and the counterparty and by the posting of collateral to a Fund to cover the Fund’s exposure to the counterparty. Each Fund pledges cash or liquid assets as collateral to satisfy the current obligations with respect to swap contracts.

 

International Swaps and Derivatives Association, Inc. Master Agreements (“ISDA Master Agreements”) govern OTC financial derivative transactions entered into by a Fund and those counterparties. The ISDA Master Agreements maintain provisions for general obligations, representations, agreements, collateral and events of default or termination. Events of termination include conditions that may entitle counterparties to elect to terminate early and cause settlement of all outstanding transactions under the applicable ISDA Master Agreement. Any election to early terminate could be material to the financial statements.

 

During the period ended January 31, 2019, the Funds invested in swap agreements consistent with the Funds’ investment strategies to gain exposure to certain markets or indices.

 

Warrants/Rights: Each Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally give the holder the right to receive, upon exercise, a security of the issuer at a set price. Funds typically use warrants and rights in a manner similar to their use of purchased options on securities, as described in options above. Risks associated with the use of warrants and rights are generally similar to risks associated with the use of purchased options. However, warrants and rights often do not have standardized terms, and may have longer maturities and may be less liquid than exchange-traded options. In addition, the terms of warrants or rights may limit each Fund’s ability to exercise the warrants or rights at such times and in such quantities as each Fund would otherwise wish. As of and during the period ended January 31, 2019, each Fund held no warrants or rights.

 

Restricted and Illiquid Securities: Although the Funds will invest primarily in publicly traded securities, they may invest a portion of their assets (generally, 5% of its value) in restricted securities and other investments which are illiquid. Restricted securities are securities that may not be sold to the public without an effective registration statement under the Securities Act of 1933, as amended (the "Securities Act") or, if they are unregistered, may be sold only in a privately negotiated transaction or pursuant to an exemption from registration.

 

The Funds may invest in securities for which there is no readily available trading market or which are otherwise illiquid. Illiquid securities include securities legally restricted as to resale, such as commercial paper issued pursuant to Section 4(2) of the Securities Act, and securities eligible for resale pursuant to Rule 144A thereunder. Section 4(2) and Rule 144A securities may, however, be treated as liquid by Clough pursuant to procedures adopted by the Board, which require consideration of factors such as trading activity, availability of market quotations and number of dealers willing to purchase the security.

 

The restricted securities held at January 31, 2019 are identified below and are also presented in the Funds' Statement of Investments:

 

Fund  Security  % of
Net Assets
  Acquisition
Date
  Shares  Cost  Fair Value
Clough Global Dividend and Income Fund  Fairway Energy LP   0.10%  6/30/2015   130,700   $1,307,000   $81,296 
Total      0.10%          $1,307,000   $81,296 
                           
Clough Global Equity Fund  Centrexion Therapeutics   0.51%  12/18/2017   416,666    749,999    749,999 
   Fairway Energy LP   0.10%  6/30/2015   217,600    2,176,000    135,347 
   Gossamer Biosciences   0.58%  7/20/2018   264,246    850,000    850,000 
Total      1.19%          $3,775,999   $1,735,346 
                           
Clough Global Opportunities Fund  Centrexion Therapeutics   0.73%  12/18/2017   1,361,111    2,450,000    2,450,000 
   Fairway Energy LP   0.10%  6/30/2015   536,000    5,360,000    333,392 
   Gossamer Biosciences   0.49%  7/20/2018   512,948    1,650,000    1,650,000 
Total      1.32%          $9,460,000   $4,433,392 

 

 

Counterparty Risk: Each of the Funds run the risk that the issuer or guarantor of a fixed income security, the counterparty to an over-the-counter derivatives contract, a borrower of each Fund’s securities or the obligor of an obligation underlying an asset-backed security will be unable or unwilling to make timely principal, interest, or settlement payments or otherwise honor its obligations. In addition, to the extent that each of the Funds use over-the-counter derivatives, and/or has significant exposure to a single counterparty, this risk will be particularly pronounced for each of the Funds.

 

Other Risk Factors: Investing in the Funds may involve certain risks including, but not limited to, the following:

 

Unforeseen developments in market conditions may result in the decline of prices of, and the income generated by, the securities held by the Funds. These events may have adverse effects on the Funds such as a decline in the value and liquidity of many securities held by the Funds, and a decrease in net asset value. Such unforeseen developments may limit or preclude the Funds’ ability to achieve their investment objective.

 

Investing in stocks may involve larger price fluctuation and greater potential for loss than other types of investments. This may result in the securities held by the Funds being subject to larger short-term declines in value compared to other types of investments.

 

The Funds may have elements of risk due to concentrated investments in foreign issuers located in a specific country. Such concentrations may subject the Funds to additional risks resulting from future political or economic conditions and/or possible impositions of adverse foreign governmental laws or currency exchange restrictions. Investments in securities of non-U.S. issuers have unique risks not present in securities of U.S. issuers, such as greater price volatility and less liquidity.

 

Fixed income securities are subject to credit risk, which is the possibility that a security could have its credit rating downgraded or that the issuer of the security could fail to make timely payments or default on payments of interest or principal. Additionally, fixed income securities are subject to interest rate risk, meaning the decline in the price of debt securities that accompanies a rise in interest rates. Bonds with longer maturities are subject to greater price fluctuations than bonds with shorter maturities.

 

The Funds invest in bonds which are rated below investment grade. These high yield bonds may be more susceptible than higher grade bonds to real or perceived adverse economic or industry conditions. The secondary market, on which high yield bonds are traded, may also be less liquid than the market for higher grade bonds.

 

2. CommitTed facility agreement

 

 

Each Fund entered into a financing package that includes a Committed Facility Agreement (the “Agreement”) dated January 16, 2009, as amended, between each Fund and BNP Paribas Prime Brokerage, Inc. (“BNP”) that allows each Fund to borrow funds from BNP. Each Fund entered a Special Custody and Pledge Agreement (the “Pledge Agreement”) dated December 9, 2013, as amended, between each Fund, the Funds’ custodian, and BNP. As of October 31, 2016, the Pledge Agreement was assigned from BNP to BNP Paribas Prime Brokerage International, Ltd. Per the Pledge Agreement, borrowings under the Agreement are secured by assets of each Fund that are held by the Fund’s custodian in a separate account (the “pledged collateral”). On January 31, 2019, the pledged collateral was valued at $80,469,565, $147,677,966 and $331,473,013 for the Clough Global Dividend and Income Fund, Clough Global Equity Fund and Clough Global Opportunities Fund, respectively. Each Fund may, with 30 days notice, reduce the Maximum Commitment Financing (Initial Limit amount plus the increased borrowing amount in excess of the Initial Limit) to a lesser amount if drawing on the full amount would result in a violation of the applicable asset coverage requirement of Section 18 of the 1940 Act. Interest is charged at the three month LIBOR (London Inter-bank Offered Rate) plus 0.70% on the amount borrowed and 0.65% on the undrawn balance. Each Fund also pays a one-time arrangement fee of 0.25% on (i) the Initial Limit and (ii) any increased borrowing amount in the excess of the Initial Limit, paid in monthly installments for the six months immediately following the date on which borrowings were drawn by the Fund.

 

 

The Maximum Commitment Financing allowed under the Agreement is $55,000,000, $85,000,000 and $207,000,000 for the Clough Global Dividend and Income Fund, Clough Global Equity Fund and the Clough Global Opportunities Fund, respectively. As of January 31, 2019, the outstanding borrowings for Clough Global Dividend and Income Fund, Clough Global Equity Fund and Clough Global Opportunities Fund were $47,000,000, $76,500,000 and $178,000,000, respectively. The interest rate applicable to the borrowings of Clough Global Dividend and Income Fund, Clough Global Equity Fund and Clough Global Opportunities Fund on January 31, 2019, was 3.44%.

 

The Lending Agreement is a separate side-agreement between each Fund and BNP pursuant to which BNP may borrow a portion of the pledged collateral (the “Lent Securities”) in an amount not to exceed the outstanding borrowings owed by a Fund to BNP under the Agreement. The Lending Agreement is intended to permit each Fund to significantly reduce the cost of its borrowings under the Agreement. BNP has the ability to re- register the Lent Securities in its own name or in another name other than the Fund to pledge, re-pledge, sell, lend or otherwise transfer or use the collateral with all attendant rights of ownership. (It is each Fund’s understanding that BNP will perform due diligence to determine the creditworthiness of any party that borrows Lent Securities from BNP.) Each Fund may designate any security within the pledged collateral as ineligible to be a Lent Security, provided there are eligible securities within the pledged collateral in an amount equal to the outstanding borrowing owed by a Fund. During the period in which the Lent Securities are outstanding, BNP must remit payment to each Fund equal to the amount of all dividends, interest or other distributions earned or made by the Lent Securities.

 

Under the terms of the Lending Agreement, the Lent Securities are marked to market daily, and if the value of the Lent Securities exceeds the value of the then-outstanding borrowings owed by a Fund to BNP under the Agreement (the “Current Borrowings”), BNP must, on that day, either
(1) return Lent Securities to each Fund’s custodian in an amount sufficient to cause the value of the outstanding Lent Securities to equal the Current Borrowings; or (2) post cash collateral with each Fund’s custodian equal to the difference between the value of the Lent Securities and the value of the Current Borrowings. If BNP fails to perform either of these actions as required, each Fund will recall securities, as discussed below, in an amount sufficient to cause the value of the outstanding Lent Securities to equal the Current Borrowings. Each Fund can recall any of the Lent Securities and BNP shall, to the extent commercially possible, return such security or equivalent security to each Fund’s custodian no later than three business days after such request. If a Fund recalls a Lent Security pursuant to the Lending Agreement, and BNP fails to return the Lent Securities or equivalent securities in a timely fashion, BNP shall remain liable for the ultimate delivery to each Fund’s custodian of such Lent Securities, or equivalent securities, and for any buy-in costs that the executing broker for the sales transaction may impose with respect to the failure to deliver. Should the borrower of the securities fail financially, the Funds have the right to reduce the outstanding amount of the Current Borrowings against which the pledged collateral has been secured. Although risk is mitigated by the collateral, the Funds could experience a delay in recovering their securities and possible loss of income or value if the borrower fails to return the borrowed securities. Under the terms of the Lending Agreement, each Fund shall have the right to apply and set-off an amount equal to one hundred percent (100%) of the then current fair value of such Lent Securities against the Current Borrowings. As of January 31, 2019, the value of the Lent Securities for Clough Global Dividend and Income Fund, Clough Global Equity Fund and Clough Global Opportunities Fund were $34,461,801, $64,666,504 and $142,488,318, respectively.

 

The Board has approved each Agreement and the Lending Agreement. No violations of the Agreement or the Lending Agreement have occurred during the period ended January 31, 2019.

 

 

Item 2 - Controls and Procedures.

 

(a)The registrant’s Principal Executive Officer and Principal Financial Officer have evaluated the registrant's disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) as of a date within 90 days of this filing and have concluded that the registrant's disclosure controls and procedures were effective, as of that date.

 

(b)There was no change in the registrant's internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) that occurred during the registrant's last fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting.

 

Item 3 – Exhibits.

 

(a)Separate certifications for the registrant's Principal Executive Officer and Principal Financial Officer, as required by Rule 30a-2(a) under the Investment Company Act of 1940, are attached as Ex99.CERT.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  CLOUGH GLOBAL EQUITY FUND
       
  By: /s/ Edmund J. Burke  
    Edmund J. Burke  
    President (Principal Executive Officer)  
       
  Date: March 29, 2019  

 

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

  By: /s/ Edmund J. Burke  
  Edmund J. Burke  
  President (Principal Executive Officer)  
       
  Date: March 29, 2019  
       
  By: /s/ Jeremy O. May  
  Jeremy O. May  
  Treasurer (Principal Financial Officer)  
       
  Date: March 29, 2019